Royalty Pharma PLC
NASDAQ:RPRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Royalty Pharma PLC
NASDAQ:RPRX
|
US |
|
Valeo SE
PAR:FR
|
FR |
|
Swire Pacific Ltd
HKEX:19
|
HK |
|
C
|
CF Industries Holdings Inc
SWB:C4F
|
US |
|
S
|
Singapore Telecommunications Ltd
F:SIT4
|
SG |
|
C
|
Capital One Financial Corp
XMUN:CFX
|
US |
|
W
|
Waste Management Inc
XHAN:UWS
|
US |
|
Rox Resources Ltd
ASX:RXL
|
AU |
|
A
|
Arkema SA
DUS:V1S
|
FR |
|
Grifols SA
MAD:GRF
|
ES |
|
Kasikornbank PCL
SET:KBANK
|
TH |
|
A
|
Axxzia Inc
TSE:4936
|
JP |
|
N
|
Nordic Group Ltd
SGX:MR7
|
SG |
|
S
|
Sherritt International Corp
OTC:SHERF
|
CA |
|
RTG Mining Inc
TSX:RTG
|
AU |
|
Kao Corp
TSE:4452
|
JP |
|
T
|
TBH Global Co Ltd
KRX:084870
|
KR |
|
C
|
Canada Goose Holdings Inc
NYSE:GOOS
|
CA |
|
E
|
EG Industries Bhd
KLSE:EG
|
MY |
|
M
|
Melrose Industries PLC
F:27M
|
UK |
|
S
|
Salesforce Inc
F:FOO
|
US |
|
Q
|
Quetzal Copper Corp
XTSX:SICO
|
CA |
|
Aztec Minerals Corp
XTSX:AZT
|
CA |
|
T
|
TQR PCL
SET:TQR
|
TH |
Bankruptcy Probability
Royalty Pharma PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Royalty Pharma PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Royalty Pharma PLC
NASDAQ:RPRX
|
33.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
651.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
365.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
364.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
226.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
194.7B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
306.2B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
161.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Royalty Pharma PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Royalty Pharma PLC has total debt of 8.6B USD. This includes both short-term (0 USD) and long-term (8.6B USD) debt.
You can find a full breakdown on its Balance Sheet.